The tumor-to-normal ratio of maximum uptake (Tmax/N) on 18F-BPA PET is widely used to guide decision-making regarding boron neutron capture therapy (BNCT). However, intratumoral heterogeneity of boron drug distribution may also influence clinical outcomes. Th...
Institution profile
National Cancer Center Hospital
Rank #292 · 3 unique linked submissions.
People
Top contributors
Hiroshi Igaki, MD, PhDHomare Murata, MScTomonori Goka, MScKimiteru Ito, MD, PhDSatoshi Nakamura, PhDHana Endo, BSc
Therapy Physics
In BNCT, 18F-BPA-PET evaluates boron drug distribution for treatment eligibility, but is rarely incorporated into treatment planning. A key limitation is differences in drug administration protocols between PET and BNCT, which may weaken clinical outcome-to-d...
Kimiteru Ito, MD, PhDMihiro Takemori, PhDSyuka Nishina, MScAi Nakaoka, PhDTairo Kashihara, MD, PhDHiroshi Igaki, MD, PhD
Therapy Physics
Accelerator-based boron neutron capture therapy (BNCT) system employing a solid-state lithium target has been implemented into clinical practices. However, due to the degradation of the Li target over its lifetime, periodic replacement is necessary. This stud...
Tairo Kashihara, MD, PhDSatoshi Nakamura, PhDHana Endo, BScTakahito Chiba, MSTetsu Nakaichi, PhDHiroki Nakayama, PhD
Therapy Physics